HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.020
Year range
$0.015 - $0.12
Market cap
1.14M CAD
Avg Volume
66.43K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 388.78K | 874.80% |
Net income | -396.49K | -817.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -365.39K | -1,163.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.49K | — |
Total assets | 1.04M | — |
Total liabilities | 839.10K | — |
Total equity | 197.36K | — |
Shares outstanding | 57.07M | — |
Price to book | ∞ | — |
Return on assets | -118.29% | — |
Return on capital | -141.69% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -396.49K | -817.27% |
Cash from operations | -53.23K | -265.77% |
Cash from investing | — | — |
Cash from financing | -4.88K | -100.32% |
Net change in cash | -58.11K | -103.79% |
Free cash flow | 37.34K | — |
About
Headquarters
Website